Contrary to expectations, high-dose chromium supplementation does not improve blood-sugar control or other parameters in obese patients with poorly controlled, insulin-treated type 2 diabetes, according to a new study.
Something like three out of every five patients with type 2 diabetes show signs of vitamin D deficiency, Italian researchers report in the medical journal Diabetes Care.
Men who sleep too much or too little are at an increased risk of developing Type 2 diabetes, according to a study by the New England Research Institutes in collaboration with Yale School of Medicine researchers.
The high-protein Atkins diet has caused a “life-threatening complication” for a woman who strictly followed the diet, say US doctors.
Gestational diabetes mellitus appears to increase the risk of developing diabetes later in life, Finnish investigators report in Diabetes Care.
Women who have habitually low levels of calcium in their diet undergo significant changes in bone calcium turnover during pregnancy and lactation, according to the results of a new study.
Levels of unhealthy blood pressure are on the decline worldwide, a new study shows, but experts aren’t sure why.
Diabetes is a disease in which the body does not properly control the amount of sugar in the blood. As a result, the level of sugar in the blood is too high. This disease occurs when the body does not produce enough insulin or does not use it properly. Here are the recommendations given by the American Diabetes Society for a healthy diet to prevent diabetes.
There is a new, potential alternative for many of the more than 5 million Americans who take insulin injections, with the Food and Drug Administration’s approval today of the first ever inhaled insulin. Exubera, an inhaled powder form of recombinant human insulin (rDNA) for the treatment of adult patients with type 1 and type 2 diabetes, is the first new insulin delivery option introduced since the discovery of insulin in the 1920s.
Buccal drug delivery pioneer, Generex, is expanding its diabetes treatment pipeline to include a new metformin chewing gum that aims to avoid the significant adverse gastrointestinal side-effects often accompanying the use of metformin tablets.